Skip to main content
Article thumbnail
Location of Repository

Identification of novel Cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo

By Anna K Walduck, Matthias Weber, Christian Wunder, Stefan Juettner, Manfred Stolte, Michael Vieth, Bertram Wiedenmann, Thomas F Meyer, Michael Naumann and Michael Hoecker
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2001). A new mathematical model for relative quantification in real-time RT-PCR.
    2. (2002). A: Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression.
    3. (2002). A: The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments. Infect Immun
    4. (2001). Aebischer T: Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect Immun
    5. (2001). AJ: Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer
    6. (2008). Backert S: Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends in Microbiology
    7. (2001). Battista JA: Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 betatreated human synovial fibroblasts.
    8. (2002). Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer
    9. (2007). CB: Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol
    10. (1994). Classification and grading of gastritis. The updated Sydney System.
    11. (2001). Crabtree JE: cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun
    12. (2006). Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.
    13. (1999). Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.
    14. (2003). De Lisle RC: Decreased gastric bacterial killing and up-regulation of protective genes in small intestine in gastrin-deficient mouse. Dig Dis Sci
    15. (2008). Dietary supplementation with carbonate increases expression of ornithine decarboxylase and proliferation in gastric mucosa in a rat model of gastric cancer.
    16. (1997). Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid. J Pharmacol Exp Ther
    17. (2003). Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?
    18. (1998). Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
    19. (2003). EG: Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci
    20. (2003). EG: Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients. Dig Dis Sci
    21. (1997). Enders G: Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology
    22. (1998). et al.: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev
    23. (1997). Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Pharmacology
    24. (2002). Expression and localization of AQP5 in the stomach and duodenum of the rat. Biochim Biophys Acta
    25. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Research
    26. (2002). Falkow S: Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection.
    27. (2003). Falkow S: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science
    28. (2003). Falkow S: Protective immunity against Helicobacter is characterized by a unique transcriptional signature.
    29. (2003). Feizi T: Interactions of the gastrotropic bacterium Helicobacter pylori with the leukocyte-endothelium adhesion molecules, the selectins – a preliminary report. FEMS Immunol Med Microbiol
    30. (2000). FK: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
    31. (1991). Fox BS: Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.
    32. (2000). Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem
    33. (1994). Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.
    34. (2002). GJ: Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin. Gastroenterology
    35. (2000). HC: Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res
    36. (2001). Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases. Dig Dis
    37. (2003). Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors. Cell Microbiol
    38. (1996). Hood L: Sequence to array: probing the genome's secrets. Nat Biotechnol
    39. (2000). I: Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/ EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts. J Dent Res
    40. (2001). Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis
    41. (2004). Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factorI receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Clinical Cancer Research
    42. (2004). JM: NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    43. (2004). LH: A role for the immunological synapse in lineage commitment of CD4 lymphocytes.
    44. (1997). MF: A Standardized Mouse Model of Helicobacter pylori infection: Introducing the Sydney strain. Gasteroenterology
    45. (2002). MM: COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.
    46. (2000). NaglerAnderson C: Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med
    47. (2000). normal, inflamed, and ulcerated human gastric mucosa. Gut
    48. (1996). Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence.
    49. (2000). Pathophysiology of antibiotic resistance: clarithromycin.
    50. (2000). PD: Helicobacter pylori -induced mucosal inflammation is Th1 mediated and exacerbated in IL-4 not IFN-γ, gene-deficient mice.
    51. (2001). Peskar BM: Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut
    52. (1986). Recent advances in the biochemistry of polyamines in eukaryotes.
    53. (2008). Schonthal AH: COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro. Mol Cancer
    54. (2002). Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther
    55. (2001). Sugihara K: Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer
    56. (2001). Sung JJ: Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment Pharmacol Ther
    57. (1996). T: Helicobacter pylori extract stimulates inflammatory nitric oxide production. Cancer Letters
    58. (2002). TC: Gastric cancer: laboratory bench to clinic.
    59. (2004). TF: Proteomic and gene profiling to study host responses to bacterial infection. Current Opinion in Microbiology
    60. (2004). TF: Transcription profiling analysis of the mechanisms of vaccine-induced protection against H.
    61. (2000). TF: Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol
    62. (2001). TH:
    63. (2008). The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype – A link to gastric carcinogenesis. Cancer Lett
    64. (2002). The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis.
    65. (2000). Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science
    66. (2008). Walduck AK: Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori. Helicobacter
    67. (2003). Wang TC: Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Research
    68. (2001). Why there are two cyclooxygenase isozymes.
    69. (2003). Xia HH: Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Molecular Pathology
    70. (2002). Zarrilli R: NSAIDs counteract H. pylori VacA toxin-induced cell vacuolation in MKN 28 gastric mucosal cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.